Literature DB >> 34536614

Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome.

Olga Staudacher1, Renate Krüger2, Uwe Kölsch3, Stephanie Thee2, Alexander Gratopp2, Volker Wahn2, Susanne Lau4, Horst von Bernuth5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34536614     DOI： 10.1016/j.jaip.2021.08.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

Review 1.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

2.  Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome.

Authors:  Caterina Matucci-Cerinic; Gianmaria Viglizzo; Carlotta Pastorino; Anna Corcione; Ignazia Prigione; Paola Bocca; Marta Bustaffa; Massimiliano Cecconi; Marco Gattorno; Stefano Volpi
Journal:  Pediatr Allergy Immunol       Date:  2022-04       Impact factor: 5.464
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.